^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Hu8F4

    i
    Other names: Hu8F4
    Associations
    News
    Trials
    Company:
    UT MD Anderson Cancer Center
    Drug class:
    PR1 inhibitor
    Associations
    News
    Trials